Towards the clinical implementation of pharmacogenetics in bipolar disorder

BACKGROUND: Bipolar disorder (BD) is a psychiatric illness defined by pathological alterations between the mood states of mania and depression, causing disability, imposing healthcare costs and elevating the risk of suicide. Although effective treatments for BD exist, variability in outcomes leads t...

Descripción completa

Detalles Bibliográficos
Autores principales: Salloum, Naji C, McCarthy, Michael J, Leckband, Susan G, Kelsoe, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039055/
https://www.ncbi.nlm.nih.gov/pubmed/24885933
http://dx.doi.org/10.1186/1741-7015-12-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039055/
https://www.ncbi.nlm.nih.gov/pubmed/24885933
http://dx.doi.org/10.1186/1741-7015-12-90

Ejemplares similares